UPDATE 2-FDA approves first generic version of Teva MS drug Copaxone

April 16, 2015 6:26 PM

7 0

April 16 (Reuters) - The U.S. Food and Drug Administration approved on Thursday the first generic version of Teva Pharmaceutical Industries Ltd's top-selling multiple sclerosis drug, Copaxone.

The generic drug, Glatopa, was developed collaboratively by Sandoz, a unit of Swiss drugmaker Novartis AG, and Momenta Pharmaceuticals Inc, for treating patients with relapsing forms of the chronic neurodegenerative disease.

Also read: Advent, Bain Capital agree to buy payments group Concardis

Read more

To category page

Loading...